Gene therapy shows promise for breast and ovarian cancer.

Reports on the March 1998 meeting of the Society of Gynecologic Investigation in Atlanta, Georgia, which discussed genetic causes of and gene therapies for breast and ovarian cancer. Report by D.G. Kieback of the Baylor College of Medicine in Houston, Texas, on the PROGINs allele of the human progesterone receptor; Report by O. Dorigo of the University of California at Los Angeles School of Medicine, on immunotherapy.